Nuvation Bio Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 83.2M | 41.9M | 13.1M | 4.8M | 3.1M | 5.7M | 727K | 1.4M |
| Cost of Goods Sold | 5.6M | 423K | 3.3M | 2.6M | 2.1M | 4.2M | 1.5M | 1.3M |
| Gross Profit | 77.6M | 41.4M | 9.8M | 2.3M | 990K | 1.5M | -788K | 88K |
| R&D Expenses | 35.0M | 34.3M | 28.8M | 27.4M | 24.6M | 29.3M | 27.7M | 454.3M |
| Operating Expenses | 73.7M | 75.5M | 66.2M | 65.8M | 60.0M | 55.4M | 47.3M | 470.5M |
| Operating Income | 3.9M | -34.0M | -56.4M | -63.6M | -59.0M | -53.9M | -48.1M | -470.4M |
| Other Income / Gains | 1.5M | -2.6M | 642K | 4.6M | 5.8M | 4.5M | 6.9M | 7.9M |
| Net Income | 5.4M | -36.6M | -55.8M | -59.0M | -53.2M | -49.4M | -41.2M | -462.5M |
| EPS (Diluted) | 0.016 | -0.11 | -0.16 | -0.17 | -0.16 | -0.15 | -0.15 | -1.89 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.933 | 0.99 | 0.745 | 0.467 | 0.321 | 0.262 | -1.084 | 0.061 |
| General And Administrative Expenses | 0 | 0 | 36.9M | 37.6M | 0 | 25.4M | 18.9M | 15.7M |
| Selling And Marketing Expenses | 0 | 0 | 500K | 900K | 0 | 700K | 700K | 500K |
| Selling General And Administrative Expenses | 38.3M | 40.3M | 37.4M | 38.5M | 35.4M | 26.1M | 19.6M | 16.2M |
| Other Expenses | 375K | 856K | 0 | 0 | 0 | 0 | 0 | 1.00 |
| Cost And Expenses | 79.3M | 75.9M | 69.6M | 68.4M | 62.1M | 59.7M | 48.8M | 471.8M |
| Interest Income | 5.1M | 5.3M | 6.0M | 4.8M | 5.3M | 6.1M | 6.7M | 7.1M |
| Interest Expense | 6.7M | 6.7M | 6.5M | 421K | 54K | 89K | 120K | 132K |
| Depreciation And Amortization | 536K | 539K | 534K | 356K | 310K | 219K | 162K | 244K |
| Ebitda | 12.6M | -29.4M | -54.8M | -58.2M | -52.9M | -49.1M | -40.9M | -462.1M |
| Ebitdaratio | 0.152 | -0.702 | -4.174 | -12.048 | -17.144 | -8.604 | -56.297 | -322.032 |
| Operating Income Ratio | 0.047 | -0.813 | -4.301 | -13.157 | -19.132 | -9.445 | -66.164 | -327.794 |
| Income Before Tax | 5.4M | -36.6M | -55.8M | -59.0M | -53.2M | -49.4M | -41.2M | -462.5M |
| Income Before Tax Ratio | 0.065 | -0.874 | -4.252 | -12.209 | -17.262 | -8.658 | -56.685 | -322.294 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0.065 | -0.874 | -4.252 | -12.209 | -17.262 | -8.658 | -56.685 | -322.294 |
| Epsdiluted | 0.014 | -0.11 | -0.16 | -0.17 | -0.16 | -0.15 | -0.15 | -1.89 |
| Weighted Average Shs Out | 347.3M | 344.3M | 342.4M | 340.7M | 338.6M | 336.9M | 273.6M | 244.7M |
| Weighted Average Shs Out Dil | 377.5M | 344.3M | 342.4M | 340.7M | 338.6M | 336.9M | 273.6M | 244.7M |